Levin Sedran & Berman LLP is investigating potential cancer cases relating to the Zantac (Ranitidine) and Store-Brand Ranitidine products.

Sanofi, the manufacturer of Zantac, has recalled its over-the-counter heartburn medication following evidence that the drug breaks down in the body into a cancer-causing chemical, NDMA. NDMA is classified as a probable human carcinogen based on laboratory tests and a known environmental contaminant.

Several manufacturers of the generic versions of Zantac, called Ranitidine, have recalled their products and major chains, including Walgreens, CVS, and Walmart have pulled the medication from the shelves. Canada and other countries have requested a suspension of distribution of all Ranitidine products.

If you have been diagnosed with one of the cancers listed below after taking a Ranitidine product, you may have a case.